These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 37767397)

  • 1. The pivotal role of EMT-related noncoding RNAs regulatory axes in hepatocellular carcinoma.
    Ghionescu AV; Sorop A; Dima SO
    Front Pharmacol; 2023; 14():1270425. PubMed ID: 37767397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Underlying Mechanisms of Noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma.
    Wang M; Yu F; Chen X; Li P; Wang K
    Mol Ther Nucleic Acids; 2020 Sep; 21():13-27. PubMed ID: 32505000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Potential Roles of Exosomal Non-Coding RNAs in Hepatocellular Carcinoma.
    Wang W; Hao LP; Song H; Chu XY; Wang R
    Front Oncol; 2022; 12():790916. PubMed ID: 35280805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosome encapsulated ncRNAs in the development of HCC: potential circulatory biomarkers and clinical therapeutic targets.
    Wang M; Wang Y; Ye F; Yu K; Wei W; Liu M; Wang R; Cui S
    Am J Cancer Res; 2021; 11(8):3794-3812. PubMed ID: 34522450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jianpi Huayu decoction inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling.
    Xie CF; Feng KL; Wang JN; Luo R; Fang CK; Zhang Y; Shen CP; Zhong C
    J Ethnopharmacol; 2022 Aug; 294():115360. PubMed ID: 35568116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncoding RNA-mediated molecular bases of chemotherapy resistance in hepatocellular carcinoma.
    He Q; Guo P; Bo Z; Yu H; Yang J; Wang Y; Chen G
    Cancer Cell Int; 2022 Aug; 22(1):249. PubMed ID: 35945536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging roles of non-coding competing endogenous RNA in hepatocellular carcinoma.
    Xu G; Xu WY; Xiao Y; Jin B; Du SD; Mao YL; Zhang ZT
    Cancer Cell Int; 2020; 20():496. PubMed ID: 33061848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA LIMT (LINC01089) contributes to sorafenib chemoresistance via regulation of miR-665 and epithelial to mesenchymal transition in hepatocellular carcinoma cells.
    Sun J; Zheng X; Wang B; Cai Y; Zheng L; Hu L; Lu X; Xie S; Zhang X; Liu H; Ye L
    Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(2):261-270. PubMed ID: 35130616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal Non-Coding RNAs: New Insights into the Biology of Hepatocellular Carcinoma.
    Zhang Q; Li H; Liu Y; Li J; Wu C; Tang H
    Curr Oncol; 2022 Jul; 29(8):5383-5406. PubMed ID: 36005165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncoding RNA-mediated macrophage and cancer cell crosstalk in hepatocellular carcinoma.
    Zhou Z; Wang Z; Gao J; Lin Z; Wang Y; Shan P; Li M; Zhou T; Li P
    Mol Ther Oncolytics; 2022 Jun; 25():98-120. PubMed ID: 35506150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of exosomal noncoding RNAs in hepatocellular carcinoma: a narrative review.
    Yoo JS; Kang MK
    J Yeungnam Med Sci; 2024 Feb; ():. PubMed ID: 38325815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological Roles and Clinical Significance of Exosome-Derived Noncoding RNAs in Bladder Cancer.
    Tong Y; Liu X; Xia D; Peng E; Yang X; Liu H; Ye T; Wang X; He Y; Xu H; Ye Z; Chen Z; Tang K
    Front Oncol; 2021; 11():704703. PubMed ID: 34692482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Emerging Roles of Exosomes in the Chemoresistance of Hepatocellular Carcinoma.
    Zhang J; Song Q; Wu M; Zheng W
    Curr Med Chem; 2021; 28(1):93-109. PubMed ID: 32000636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosome-derived noncoding RNAs in gastric cancer: functions and clinical applications.
    Tang XH; Guo T; Gao XY; Wu XL; Xing XF; Ji JF; Li ZY
    Mol Cancer; 2021 Jul; 20(1):99. PubMed ID: 34330299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential.
    Han Q; Wang M; Dong X; Wei F; Luo Y; Sun X
    Front Immunol; 2022; 13():985815. PubMed ID: 36300115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma.
    Liao W; Du J; Wang Z; Feng Q; Liao M; Liu H; Yuan K; Zeng Y
    Int J Cancer; 2022 Aug; 151(3):337-347. PubMed ID: 35460073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal Non-Coding RNAs: Regulatory and Therapeutic Target of Hepatocellular Carcinoma.
    Xia H; Huang Z; Liu S; Zhao X; He R; Wang Z; Shi W; Chen W; Li Z; Yu L; Huang P; Kang P; Su Z; Xu Y; Yam JWP; Cui Y
    Front Oncol; 2021; 11():653846. PubMed ID: 33869059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA-POIR promotes epithelial-mesenchymal transition and suppresses sorafenib sensitivity simultaneously in hepatocellular carcinoma by sponging miR-182-5p.
    Chen BW; Zhou Y; Wei T; Wen L; Zhang YB; Shen SC; Zhang J; Ma T; Chen W; Ni L; Wang Y; Bai XL; Liang TB
    J Cell Biochem; 2021 Jan; 122(1):130-142. PubMed ID: 32951268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic targeting of noncoding RNAs in hepatocellular carcinoma: Recent progress and future prospects.
    Xiao Z; Shen J; Zhang L; Li M; Hu W; Cho C
    Oncol Lett; 2018 Mar; 15(3):3395-3402. PubMed ID: 29467864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
    Drak Alsibai K; Meseure D
    Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.